Many women spend decades using birth control of one kind or another, except for when they’re trying to conceive or are pregnant. So when you know you’re done having babies or if you plan to stay child ...

ATLANTA, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and cost-effective to ...

If you’re ready to make the life-altering decision to obtain permanent birth control, check out our list of 4 easiest forms of permanent birth control for men and women. While many people are actively ...

ATLANTA, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (FEMY) (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and ...

Publication of positive data in a leading peer-reviewed journal enhances credibility and visibility for FemBloc, attracting interest from the medical community. The reported pregnancy rate of 0% among ...

Vasectomy: The Ultimate Birth Control? Considering a vasectomy? Learn about its effectiveness, risks, and impact on sexual performance. Make an informed choice!...see more Since the Supreme Court ...

A pro-choice demonstrator in front of the U.S. Supreme Court. The number of women seeking permanent birth control — via tubal ligation — has increased more than 50% following the Supreme Court’s 2022 ...

At the request of the Food and Drug Administration, Leverkusen, Germany-based Bayer will now add a box warning and patient decision checklist to the label of its permanent birth control device Essure.

・Femasys secured FDA approval to proceed with the final phase of its pivotal FemBloc trial, a key step toward U.S. market approval for its non-surgical permanent birth control device. ・The company ...

-- FemBloc becomes the latest Femasys product to achieve MDSAP certification, building on a proven track record of compliance -- ATLANTA, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), ...